NUT carcinoma is a rare, aggressive cancer defined by rearrangements of the NUTM1 gene.
No routinely effective treatments of NUT carcinoma exist, despite harboring a targetable …

Nuclear protein in testis (NUT) carcinoma is a rare, highly aggressive, poorly differentiated
carcinoma occurring mostly in adolescents and young adults. This tumor usually arises from …

NUT carcinoma (NC) is a rare and highly aggressive malignancy with a dismal prognosis
and a median survival of 6–9 months only. Although very few cases of NC are reported each …

NUT carcinoma (NC) is a rare, aggressive subtype of squamous cell carcinoma defined by
rearrangement of the NUTM1 (aka NUT) gene. NC is driven by NUT‐fusion oncoproteins …

NUT carcinoma (NC) is defined molecularly by rearrangement of the NUTM1 gene and is
most commonly driven by the BRD4-NUT oncoprotein. Patients are typically in their teens or …

NUT carcinoma (NC) is a rare and poorly differentiated tumor, with highly aggressive and
fatal neoplasm. NC is characterized by chromosomal rearrangement involving NUTM1 …

NUT midline carcinoma (NMC) is a rare and aggressive cancer, with survival typically less
than seven months, that can arise in people of any age. Genetically, NMC is defined by the …

Background NUT carcinoma is a rare aggressive disease caused by BRD4/3‐NUT fusion,
and C‐MYC upregulation plays a key role in the pathogenesis. Here, we report on the …

NUT midline carcinoma, a squamous cell carcinoma, is one of the most aggressive human
cancers, and there is a desperate need for effective therapies for patients with this disease …

Nuclear protein in testis (NUT)-midline carcinoma (NMC) is a rare, aggressive disease
typically presenting with a single t (15; 19) translocation that results in the generation of a …